Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance

Aim. The present study aimed to establish inhibin A and B serum levels during the menstrual cycle of obese women, and its usefulness as an index of luteal-phase follicular development. Materials and methods. Twenty-one obese patients (mean body mass index: 34.9 ± 3.7 kg/m2; range: 30.0-45.0 kg/m2) w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecological endocrinology 2005-07, Vol.21 (1), p.7-11
Hauptverfasser: Auge, Antonio Pedro, Longui, Carlos Alberto, Almeida Prado, Roberto A, Neves, Mylene Rocha, Hirota, Andrea, Busso, Newton Eduardo, Monte, Osmar, Aldrighi, José Mendes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11
container_issue 1
container_start_page 7
container_title Gynecological endocrinology
container_volume 21
creator Auge, Antonio Pedro
Longui, Carlos Alberto
Almeida Prado, Roberto A
Neves, Mylene Rocha
Hirota, Andrea
Busso, Newton Eduardo
Monte, Osmar
Aldrighi, José Mendes
description Aim. The present study aimed to establish inhibin A and B serum levels during the menstrual cycle of obese women, and its usefulness as an index of luteal-phase follicular development. Materials and methods. Twenty-one obese patients (mean body mass index: 34.9 ± 3.7 kg/m2; range: 30.0-45.0 kg/m2) were submitted to basal hormonal measurements and an oral glucose tolerance test after challenge with 75 g glucose. Progesterone and inhibin A and B levels were determined 5-7 days after the menstrual cycle and 7 days prior to expected menses. Results. As expected, an increase in inhibin A and a decrease in inhibin B were observed when first-phase samples were compared with samples obtained after 15-20 days. On the other hand, the percentage variation of both inhibin A and B was at least four times smaller than the values for normal women described previously by other authors employing the same enzyme-linked immunosorbent assays. A small number of obese women presented ovulatory cycles characterized by progesterone concentration higher than 5.8 ng/ml. The percentage elevation ( > 190%) of inhibin A in the second samples was in agreement with the progesterone levels, but it seemed to be more sensitive for the detection of follicle luteinization. Conclusion. We conclude that obese women present less percentage variation of both inhibin A and B during the menstrual cycle, associated with a low frequency of ovulatory cycles. In obese women, the percentage increase of inhibin A can represent an additional marker to recognize follicle luteinization.
doi_str_mv 10.1080/09513590500128716
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_09513590500128716</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68083965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-adacf9da720094a83aa42032f1fb440145d36db86a22186d5309588a9063824b3</originalsourceid><addsrcrecordid>eNp9kE9P3DAQxa0KVBbaD9ALijhwC4xjx7EFl2UFFAmpl_ZYWZPE0RolNtiJVnz7Ouyqf0D0NB7P7z3NPEK-UDijIOEcVElZqaAEoIWsqPhAFpRXLIdKiD2ymOf5DByQwxgfEsV4VXwkB1QAl5UqF-TnsnY-DNhn1q1tbV22zNC1v7urLJommNF6l_4yX5toso0fjMs2dly_sPPDT2Oax6lPUDDRxhFdYz6R_Q77aD7v6hH5cXP9ffU1v_92e7da3ucNZ3TMscWmUy1WBYDiKBkiL4AVHe1qzoHysmWiraXAoqBStCVLl0mJCgSTBa_ZETnd-j4G_zSZOOrBxsb0PTrjp6iFBMmUKBN48gp88FNwaTdNVcWpAqYSRLdQE3yMwXT6MdgBw7OmoOfg9Zvgk-Z4ZzzVg2n_KHZJJ-ByC1jXzYFvfOhbPeJz70MXUlg2avY__4t_5GuD_bhuMJi_LnhX_QuPtqGj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>197419039</pqid></control><display><type>article</type><title>Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance</title><source>Taylor &amp; Francis</source><source>MEDLINE</source><creator>Auge, Antonio Pedro ; Longui, Carlos Alberto ; Almeida Prado, Roberto A ; Neves, Mylene Rocha ; Hirota, Andrea ; Busso, Newton Eduardo ; Monte, Osmar ; Aldrighi, José Mendes</creator><creatorcontrib>Auge, Antonio Pedro ; Longui, Carlos Alberto ; Almeida Prado, Roberto A ; Neves, Mylene Rocha ; Hirota, Andrea ; Busso, Newton Eduardo ; Monte, Osmar ; Aldrighi, José Mendes</creatorcontrib><description>Aim. The present study aimed to establish inhibin A and B serum levels during the menstrual cycle of obese women, and its usefulness as an index of luteal-phase follicular development. Materials and methods. Twenty-one obese patients (mean body mass index: 34.9 ± 3.7 kg/m2; range: 30.0-45.0 kg/m2) were submitted to basal hormonal measurements and an oral glucose tolerance test after challenge with 75 g glucose. Progesterone and inhibin A and B levels were determined 5-7 days after the menstrual cycle and 7 days prior to expected menses. Results. As expected, an increase in inhibin A and a decrease in inhibin B were observed when first-phase samples were compared with samples obtained after 15-20 days. On the other hand, the percentage variation of both inhibin A and B was at least four times smaller than the values for normal women described previously by other authors employing the same enzyme-linked immunosorbent assays. A small number of obese women presented ovulatory cycles characterized by progesterone concentration higher than 5.8 ng/ml. The percentage elevation ( &gt; 190%) of inhibin A in the second samples was in agreement with the progesterone levels, but it seemed to be more sensitive for the detection of follicle luteinization. Conclusion. We conclude that obese women present less percentage variation of both inhibin A and B during the menstrual cycle, associated with a low frequency of ovulatory cycles. In obese women, the percentage increase of inhibin A can represent an additional marker to recognize follicle luteinization.</description><identifier>ISSN: 0951-3590</identifier><identifier>EISSN: 1473-0766</identifier><identifier>DOI: 10.1080/09513590500128716</identifier><identifier>PMID: 16048795</identifier><identifier>CODEN: GYENER</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; anovulation ; Body Mass Index ; Female ; Follicle Stimulating Hormone - blood ; follicular luteinization ; Glucose Tolerance Test ; Humans ; inhibin ; Inhibins - secretion ; Insulin - blood ; Insulin Resistance ; Insulin-Like Growth Factor I - analysis ; Luteinizing Hormone - blood ; Menstrual Cycle - blood ; Middle Aged ; Obesity ; Obesity - physiopathology ; Ovulation ; Progesterone - blood ; Prospective Studies ; Sex Hormone-Binding Globulin - analysis</subject><ispartof>Gynecological endocrinology, 2005-07, Vol.21 (1), p.7-11</ispartof><rights>2005 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2005</rights><rights>Copyright CRC Press Jul 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-adacf9da720094a83aa42032f1fb440145d36db86a22186d5309588a9063824b3</citedby><cites>FETCH-LOGICAL-c431t-adacf9da720094a83aa42032f1fb440145d36db86a22186d5309588a9063824b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/09513590500128716$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/09513590500128716$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,59620,60409,61194,61375</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16048795$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Auge, Antonio Pedro</creatorcontrib><creatorcontrib>Longui, Carlos Alberto</creatorcontrib><creatorcontrib>Almeida Prado, Roberto A</creatorcontrib><creatorcontrib>Neves, Mylene Rocha</creatorcontrib><creatorcontrib>Hirota, Andrea</creatorcontrib><creatorcontrib>Busso, Newton Eduardo</creatorcontrib><creatorcontrib>Monte, Osmar</creatorcontrib><creatorcontrib>Aldrighi, José Mendes</creatorcontrib><title>Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance</title><title>Gynecological endocrinology</title><addtitle>Gynecol Endocrinol</addtitle><description>Aim. The present study aimed to establish inhibin A and B serum levels during the menstrual cycle of obese women, and its usefulness as an index of luteal-phase follicular development. Materials and methods. Twenty-one obese patients (mean body mass index: 34.9 ± 3.7 kg/m2; range: 30.0-45.0 kg/m2) were submitted to basal hormonal measurements and an oral glucose tolerance test after challenge with 75 g glucose. Progesterone and inhibin A and B levels were determined 5-7 days after the menstrual cycle and 7 days prior to expected menses. Results. As expected, an increase in inhibin A and a decrease in inhibin B were observed when first-phase samples were compared with samples obtained after 15-20 days. On the other hand, the percentage variation of both inhibin A and B was at least four times smaller than the values for normal women described previously by other authors employing the same enzyme-linked immunosorbent assays. A small number of obese women presented ovulatory cycles characterized by progesterone concentration higher than 5.8 ng/ml. The percentage elevation ( &gt; 190%) of inhibin A in the second samples was in agreement with the progesterone levels, but it seemed to be more sensitive for the detection of follicle luteinization. Conclusion. We conclude that obese women present less percentage variation of both inhibin A and B during the menstrual cycle, associated with a low frequency of ovulatory cycles. In obese women, the percentage increase of inhibin A can represent an additional marker to recognize follicle luteinization.</description><subject>Adolescent</subject><subject>Adult</subject><subject>anovulation</subject><subject>Body Mass Index</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>follicular luteinization</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>inhibin</subject><subject>Inhibins - secretion</subject><subject>Insulin - blood</subject><subject>Insulin Resistance</subject><subject>Insulin-Like Growth Factor I - analysis</subject><subject>Luteinizing Hormone - blood</subject><subject>Menstrual Cycle - blood</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity - physiopathology</subject><subject>Ovulation</subject><subject>Progesterone - blood</subject><subject>Prospective Studies</subject><subject>Sex Hormone-Binding Globulin - analysis</subject><issn>0951-3590</issn><issn>1473-0766</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kE9P3DAQxa0KVBbaD9ALijhwC4xjx7EFl2UFFAmpl_ZYWZPE0RolNtiJVnz7Ouyqf0D0NB7P7z3NPEK-UDijIOEcVElZqaAEoIWsqPhAFpRXLIdKiD2ymOf5DByQwxgfEsV4VXwkB1QAl5UqF-TnsnY-DNhn1q1tbV22zNC1v7urLJommNF6l_4yX5toso0fjMs2dly_sPPDT2Oax6lPUDDRxhFdYz6R_Q77aD7v6hH5cXP9ffU1v_92e7da3ucNZ3TMscWmUy1WBYDiKBkiL4AVHe1qzoHysmWiraXAoqBStCVLl0mJCgSTBa_ZETnd-j4G_zSZOOrBxsb0PTrjp6iFBMmUKBN48gp88FNwaTdNVcWpAqYSRLdQE3yMwXT6MdgBw7OmoOfg9Zvgk-Z4ZzzVg2n_KHZJJ-ByC1jXzYFvfOhbPeJz70MXUlg2avY__4t_5GuD_bhuMJi_LnhX_QuPtqGj</recordid><startdate>200507</startdate><enddate>200507</enddate><creator>Auge, Antonio Pedro</creator><creator>Longui, Carlos Alberto</creator><creator>Almeida Prado, Roberto A</creator><creator>Neves, Mylene Rocha</creator><creator>Hirota, Andrea</creator><creator>Busso, Newton Eduardo</creator><creator>Monte, Osmar</creator><creator>Aldrighi, José Mendes</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>200507</creationdate><title>Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance</title><author>Auge, Antonio Pedro ; Longui, Carlos Alberto ; Almeida Prado, Roberto A ; Neves, Mylene Rocha ; Hirota, Andrea ; Busso, Newton Eduardo ; Monte, Osmar ; Aldrighi, José Mendes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-adacf9da720094a83aa42032f1fb440145d36db86a22186d5309588a9063824b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>anovulation</topic><topic>Body Mass Index</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>follicular luteinization</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>inhibin</topic><topic>Inhibins - secretion</topic><topic>Insulin - blood</topic><topic>Insulin Resistance</topic><topic>Insulin-Like Growth Factor I - analysis</topic><topic>Luteinizing Hormone - blood</topic><topic>Menstrual Cycle - blood</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity - physiopathology</topic><topic>Ovulation</topic><topic>Progesterone - blood</topic><topic>Prospective Studies</topic><topic>Sex Hormone-Binding Globulin - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Auge, Antonio Pedro</creatorcontrib><creatorcontrib>Longui, Carlos Alberto</creatorcontrib><creatorcontrib>Almeida Prado, Roberto A</creatorcontrib><creatorcontrib>Neves, Mylene Rocha</creatorcontrib><creatorcontrib>Hirota, Andrea</creatorcontrib><creatorcontrib>Busso, Newton Eduardo</creatorcontrib><creatorcontrib>Monte, Osmar</creatorcontrib><creatorcontrib>Aldrighi, José Mendes</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecological endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Auge, Antonio Pedro</au><au>Longui, Carlos Alberto</au><au>Almeida Prado, Roberto A</au><au>Neves, Mylene Rocha</au><au>Hirota, Andrea</au><au>Busso, Newton Eduardo</au><au>Monte, Osmar</au><au>Aldrighi, José Mendes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance</atitle><jtitle>Gynecological endocrinology</jtitle><addtitle>Gynecol Endocrinol</addtitle><date>2005-07</date><risdate>2005</risdate><volume>21</volume><issue>1</issue><spage>7</spage><epage>11</epage><pages>7-11</pages><issn>0951-3590</issn><eissn>1473-0766</eissn><coden>GYENER</coden><abstract>Aim. The present study aimed to establish inhibin A and B serum levels during the menstrual cycle of obese women, and its usefulness as an index of luteal-phase follicular development. Materials and methods. Twenty-one obese patients (mean body mass index: 34.9 ± 3.7 kg/m2; range: 30.0-45.0 kg/m2) were submitted to basal hormonal measurements and an oral glucose tolerance test after challenge with 75 g glucose. Progesterone and inhibin A and B levels were determined 5-7 days after the menstrual cycle and 7 days prior to expected menses. Results. As expected, an increase in inhibin A and a decrease in inhibin B were observed when first-phase samples were compared with samples obtained after 15-20 days. On the other hand, the percentage variation of both inhibin A and B was at least four times smaller than the values for normal women described previously by other authors employing the same enzyme-linked immunosorbent assays. A small number of obese women presented ovulatory cycles characterized by progesterone concentration higher than 5.8 ng/ml. The percentage elevation ( &gt; 190%) of inhibin A in the second samples was in agreement with the progesterone levels, but it seemed to be more sensitive for the detection of follicle luteinization. Conclusion. We conclude that obese women present less percentage variation of both inhibin A and B during the menstrual cycle, associated with a low frequency of ovulatory cycles. In obese women, the percentage increase of inhibin A can represent an additional marker to recognize follicle luteinization.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>16048795</pmid><doi>10.1080/09513590500128716</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0951-3590
ispartof Gynecological endocrinology, 2005-07, Vol.21 (1), p.7-11
issn 0951-3590
1473-0766
language eng
recordid cdi_crossref_primary_10_1080_09513590500128716
source Taylor & Francis; MEDLINE
subjects Adolescent
Adult
anovulation
Body Mass Index
Female
Follicle Stimulating Hormone - blood
follicular luteinization
Glucose Tolerance Test
Humans
inhibin
Inhibins - secretion
Insulin - blood
Insulin Resistance
Insulin-Like Growth Factor I - analysis
Luteinizing Hormone - blood
Menstrual Cycle - blood
Middle Aged
Obesity
Obesity - physiopathology
Ovulation
Progesterone - blood
Prospective Studies
Sex Hormone-Binding Globulin - analysis
title Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T14%3A57%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abnormal%20inhibin%20A%20and%20inhibin%20B%20secretion%20in%20obese%20women%20with%20and%20without%20insulin%20resistance&rft.jtitle=Gynecological%20endocrinology&rft.au=Auge,%20Antonio%20Pedro&rft.date=2005-07&rft.volume=21&rft.issue=1&rft.spage=7&rft.epage=11&rft.pages=7-11&rft.issn=0951-3590&rft.eissn=1473-0766&rft.coden=GYENER&rft_id=info:doi/10.1080/09513590500128716&rft_dat=%3Cproquest_cross%3E68083965%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=197419039&rft_id=info:pmid/16048795&rfr_iscdi=true